iTEAR100 Generation 2

· Olympic Ophthalmics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for iTEAR100 Generation 2, covering 2022-03-31 to 2022-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Usability Study of External Neuromodulation With iTEAR100 Generation 2 [Phase 4]